Consensus Genpact Limited Börse Stuttgart

Stocks

35G

BMG3922B1072

Business Support Services

Market Closed - Börse Stuttgart 23:55:17 28/08/2026 +04			5-day change	1st Jan Change
32.76 ^EUR	+1.74%		+2.66%	-18.57%

08-19	Genpact Insider Sold Shares Worth $510,545, According to a Recent SEC Filing	MT
08-14	Genpact Insider Sold Shares Worth $987,592, According to a Recent SEC Filing	MT

Evolution of the Average Target: Genpact Limited

Evolution of the Target Price: Genpact Limited

Changes in Analyst Recommendations: Genpact Limited

acece311de11267d2becb9c95b7f2c31._9YZfiOLpFPWqSnFhrF_uApOqO4kIEcdime5RZGUgDE.zLpwLhril2Tm4Xqj_INL6jkn0J19ZSVa5DjSdvTR7QKc4UtObLnAKaDKfA~10810a32c74e0ee7891087c5410a60ff

Analysts' recommendations: Genpact Limited

08-07	Analyst recommendations: Micron Technology, Lockheed Martin, Airbnb, Johnson Controls International, The Allstate Corporation…
05-11	Mizuho Securities Adjusts Genpact Price Target to $39 From $49, Maintains Neutral Rating	MT
12-12	Susquehanna Initiates Genpact With Neutral Rating, $50 Price Target	MT
08/08/25	Genpact Q2 revenue, adjusted profit beats estimates	RE
27/06/25	TD Cowen Raises Price Target on Genpact to $55 From $53, Maintains Buy Rating	MT
10/02/25	Analyst recommendations: Drax, AstraZeneca, HSBC, Broadcom, Tesla...
10/02/25	Analyst recommendations: Aspen, Amazon, Mattel, Broadcom, Tesla…
07/02/25	Deutsche Bank Adjusts Genpact Price Target to $55 From $48, Maintains Hold Rating	MT
07/02/25	TD Cowen Upgrades Genpact to Buy From Hold, Adjusts Price Target to $60 From $45	MT
21/01/25	Jefferies Upgrades Genpact to Buy From Hold, Adjusts Price Target to $55 From $44	MT
21/01/25	Analyst recommendations: Apple, On Holding, Amazon, Palo Alto Networks, Tesla...
11/11/24	Deutsche Bank Adjusts Genpact Price Target to $48 From $37, Maintains Hold Rating	MT
11/11/24	Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks...
17/07/24	JPMorgan Upgrades Genpact to Neutral From Underweight, Price Target is $40	MT
17/07/24	Analyst recommendations: American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly...
30/01/24	Mizuho Securities Initiates Genpact With Neutral Rating, Price Target is $40	MT
17/01/24	Citigroup Adjusts Price Target on Genpact to $36 From $35, Maintains Neutral Rating	MT
15/12/23	Baird Downgrades Genpact to Neutral From Outperform, Price Target is $38	MT
13/11/23	Wedbush Lowers Genpact's PT to $35 From $45 After Weaker-Than-Expected Q3 Results, Resets Full-Year 2023 Guidance; Keeps Neutral Rating	MT
22/08/23	JPMorgan Downgrades Genpact to Underweight From Neutral, Price Target is $40	MT
11/08/23	Needham Adjusts Genpact Price Target to $50 From $56, Maintains Buy Rating	MT
10/08/23	Deutsche Bank Adjusts Genpact Price Target to $37 From $48, Maintains Hold Rating	MT
10/08/23	BMO Capital Adjusts Price Target on Genpact to $41 From $46, Maintains Market Perform Rating	MT
18/07/23	Citigroup Downgrades Genpact to Neutral From Buy, Adjusts Price Target to $42 From $46	MT
11/05/23	JPMorgan Cuts Genpact's Price Target to $46 From $53, Neutral Rating Kept	MT

More recommendations

Other Business Support Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CINTAS CORPORATION					+5.94%
	JACOBS SOLUTIONS INC.					+6.94%
	BUREAU VERITAS SA					+18.43%
	INTERTEK GROUP PLC					+0.89%
	ALS LIMITED					+10.36%
	ISS A/S					+8.11%
	GENPACT LIMITED					+10.95%
	EXLSERVICE HOLDINGS, INC.					+16.21%
	DKSH HOLDING AG					+11.7%
	Average					+9.95%
	Weighted average by Cap.					+7.87%